Neutralizing B-Cell Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0753
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)